CelLBxHealth plc Stock
Stocks
CLBX
GB0034330679
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.375 GBX | 0.00% |
|
-8.33% | +25.00% |
| 07-07 | CelLBxHealth chief executive Collins to step down | AN |
| 07-07 | Cellbxhealth plc Announces Resignation of Peter Collins as Chief Executive Officer | CI |
| Market Cap | 15.63M 20.97M 18.34M 16.92M 29.65M 2B 30.15M 202M 79.38M 985M 78.73M 77.02M 3.39B | P/E 2025 * |
-0.24x | P/E 2026 * | -0.59x |
|---|---|---|---|---|---|
| Enterprise Value | 8.33M 11.17M 9.77M 9.01M 15.8M 1.07B 16.06M 108M 42.3M 525M 41.95M 41.04M 1.8B | EV / Sales 2025 * |
0.8x | EV / Sales 2026 * | 0.65x |
| Free-Float |
94.31% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: CelLBxHealth plc
| 16/10/25 | Angle names Peter Collins as interim CEO | AN |
| 28/05/25 | RBC cuts National Grid; Citigroup cuts South32 | AN |
| 23/01/25 | HSBC raises FirstGroup, Goldman cuts Ithaca | AN |
| 14/09/23 | JPMorgan ups Rio Tinto; Redburn likes Carnival | AN |
| 24/01/22 | Berenberg Initiates Angle With Buy Rating, Sets PT | MT |
| 1 week | -8.33% | ||
| Current month | -9.84% | ||
| 1 month | -25.68% | ||
| 3 months | +52.78% | ||
| 6 months | +30.95% | ||
| Current year | +25.00% |
| 1 week | 1.35 |  | 1.67 |
| 1 month | 1.3 | | 1.85 |
| Current year | 0.85 | | 2.8 |
| 1 year | 0.85 | | 8 |
| 3 years | 0.85 | | 37.4 |
| 5 years | 0.85 | | 163.75 |
| 10 years | 0.85 | | 163.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sinéad Armstrong
DFI | Director of Finance/CFO | - | 01/01/1999 |
| Chief Tech/Sci/R&D Officer | - | 01/01/2025 | |
Karen Miller
CTO | Chief Tech/Sci/R&D Officer | - | 05/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jan Groen
CHM | Chairman | 67 | 22/05/2023 |
Klaas de Boer
BRD | Director/Board Member | 61 | 12/01/2026 |
| Director/Board Member | 61 | 12/01/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12-19 | Buy | Chief Executive Officer | 5,000,000 | 1.5497% | ||
| 12-19 | Buy | Chairman | 5,000,000 | 1.5497% | ||
| 12-19 | Buy | Chief Financial Officer | 2,500,000 | 0.7749% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -8.33% | -78.35% | -88.30% | 20.97M | |
| +3.73% | +6.80% | +7.08% | -21.25% | 17.28B | |
| +3.87% | -5.71% | +14.87% | +96.15% | 1.68B | |
| +4.76% | +0.11% | -42.09% | -78.52% | 1.25B | |
| -2.75% | -6.73% | -32.90% | +29.18% | 1.06B | |
| +2.92% | -2.22% | -29.06% | -54.36% | 626M | |
| +3.91% | -4.74% | -40.38% | -56.87% | 555M | |
| +2.60% | +4.15% | +29.39% | -52.33% | 466M | |
| +1.13% | -0.48% | -55.67% | -59.51% | 380M | |
| +2.67% | -5.46% | -26.93% | -24.21% | 342M | |
| Average | +2.28% | -1.63% | -25.40% | -31.00% | 2.37B | |
| Weighted average by Cap. | +3.40% | +4.43% | +0.05% | -16.69% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 10.35M 13.9M 12.15M 11.21M 19.65M 1.33B 19.98M 134M 52.6M 653M 52.17M 51.04M 2.24B | 21.65M 29.05M 25.41M 23.44M 41.08M 2.77B 41.77M 280M 110M 1.37B 109M 107M 4.69B |
| Net income | -16.35M -21.94M -19.19M -17.7M -31.02M -2.09B -31.55M -212M -83.06M -1.03B -82.38M -80.59M -3.54B | -8.55M -11.47M -10.04M -9.26M -16.22M -1.09B -16.5M -111M -43.44M -539M -43.08M -42.14M -1.85B |
| Net Debt | -7.3M -9.8M -8.57M -7.9M -13.85M -934M -14.08M -94.44M -37.09M -460M -36.78M -35.98M -1.58B | -1.6M -2.15M -1.88M -1.73M -3.04M -205M -3.09M -20.7M -8.13M -101M -8.06M -7.89M -347M |
Employees
119
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | GBX 1.375 | 0.00% | 857,895 |
| 09/07/26 | GBX 1.375 | -5.17% | 1,610,864 |
| 08/07/26 | GBX 1.450 | -1.69% | 2,251,058 |
| 07/07/26 | GBX 1.475 | -7.81% | 4,128,376 |
| 06/07/26 | GBX 1.600 | +6.67% | 2,912,628 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0138GBP
Average target price
0.0400GBP
Spread / Average Target
+190.91%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CLBX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
